CPTAC Launches MRM Assay Portal

Premium

NEW YORK (GenomeWeb) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium has launched an assay portal for multiple-reaction monitoring mass spec assays.

The portal currently contains MRM-MS assays to 456 unique peptides and 282 unique proteins along with related data and methodological information.

The portal is also intended as a space for researchers to share quantitative assays along with standard operating procedures and guidelines with the larger community.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.